trending Market Intelligence /marketintelligence/en/news-insights/trending/mcc1zjfxygta-fww9wxdsw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

OncBioMune Pharmaceuticals appoints director

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


OncBioMune Pharmaceuticals appoints director

OncBioMune Pharmaceuticals Inc. added Neal Holcomb to its board.

Holcomb is president and owner of Holcomb CPA Firm P.A. and serves as a director at several private companies. He was also the certified public accountant for OncBioMune LLC, before the company went public.

Baton Rouge, La.-based OncBioMune Pharmaceuticals is developing proprietary cancer vaccine technology and targeted cancer therapies.